TSS
QNRX

Two Sigma Securities’s Quoin Pharmaceuticals QNRX Stock Holding History

Two Sigma Securities’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,501
Closed -$34.2K – 2064
2024
Q4 		$34.2K Buy
1,501
+591
+65% +$13.6K ﹤0.01% 1232
2024
Q3 		$15.7K Buy
910
+240
+36% +$5.05K ﹤0.01% 2534
2024
Q2 		$13.6K Buy
+670
New +$17K ﹤0.01% 2767
2022
Q3 		– Sell
-3
Closed -$7K – 2999
2022
Q2 		$7K Buy
+3
New +$11.9K ﹤0.01% 2091
2022
Q1 		– Sell
-3
Closed -$29K – 2432
2021
Q4 		$29K Buy
+3
New +$129K ﹤0.01% 1364
2021
Q2 		– Sell
-1
Closed -$39K – 1668
2021
Q1 		$39K Buy
+1
New +$69.8K ﹤0.01% 746
2019
Q4 		– Hold
0
– -$9K – 2591
2019
Q3 		– Hold
0
– – – 2006
2019
Q2 		– Hold
0
– -$15K – 2359
2019
Q1 		– Hold
0
– – – 1697
2017
Q2 		– Hold
0
– -$98K – 1116
2017
Q1 		– Hold
0
– – – 756

Other funds holding QNRX

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Two Sigma Securities's QNRX Position: Q1 2025 in Review

Two Sigma Securities sold out of Quoin Pharmaceuticals (QNRX) in Q1 2025, closing a stake of 1,501 shares — an estimated $34.2K sold.

Two Sigma Securities first reported a position in QNRX in Q1 2021 and held it in 6 quarters. The position peaked at $39K in Q1 2021. 9 funds tracked by Wall St. Rank hold QNRX as of Q1 2025.

  • Two Sigma Securities reported no remaining Quoin Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Securities sold 1,501 Quoin Pharmaceuticals shares in Q1 2025, an estimated $34.2K.
  • Two Sigma Securities first reported a position in Quoin Pharmaceuticals in Q1 2021 and held it in 6 quarters.
  • Two Sigma Securities's Quoin Pharmaceuticals position peaked at $39K in Q1 2021.
  • 9 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q1 2025.

Based on Two Sigma Securities's 13F filing for Q1 2025, filed 15 May 2025.